Dex is highly specific and selective to glucocorticoid receptors (GR), expressed in almost every nucleus.26 Consequently, Dex has been employed to achieve cancer-cell-specific nuclear-targeted therapeutic agent delivery. This evidence concerns the gene NR3C1 and cancer.